{"hands_on_practices": [{"introduction": "Interpreting multi-dimensional genomic data is a cornerstone of modern molecular biology. This exercise challenges you to synthesize distinct epigenomic signals—histone modifications, DNA methylation, and chromatin accessibility—to deduce the state of a specific genomic locus. By integrating these data types, you will practice classifying chromatin and, more importantly, reasoning about the single most informative experiment to mechanistically confirm your conclusion [@problem_id:2944116].", "problem": "A mammalian locus exhibits the following epigenomic features when profiled in the same cell type and condition: high trimethylation of histone H3 lysine 9 ($H3K9me3$), low trimethylation of histone H3 lysine 27 ($H3K27me3$), strong cytosine DNA methylation at CpG dinucleotides, and a very low signal in Assay for Transposase-Accessible Chromatin using sequencing (ATAC-seq). Based on fundamental definitions of chromatin states and the mechanistic roles of histone modifications, classify the locus as euchromatin or heterochromatin. Then, specify a single, mechanistically informative and minimally sufficient additional measurement that would resolve any residual ambiguity about whether the locus is in the canonical constitutive heterochromatin pathway (versus being merely a closed, repressed region).\n\nFoundational facts for reasoning:\n- Euchromatin is operationally defined by relative chromatin accessibility, enrichment for activating histone marks, and active or poised transcriptional potential; heterochromatin is defined by physical compaction, gene silencing, and characteristic repressive marks together with their cognate reader proteins.\n- Trimethylation of histone H3 lysine 9 ($H3K9me3$) is a hallmark of constitutive heterochromatin and is specifically recognized by Heterochromatin Protein 1 (HP1) chromodomain proteins (for example, CBX5/HP1$\\alpha$), which promote chromatin compaction.\n- Trimethylation of histone H3 lysine 27 ($H3K27me3$) is the canonical mark of facultative heterochromatin deposited by Polycomb Repressive Complex 2 (PRC2).\n- DNA methylation at CpG sites correlates with transcriptional repression and is commonly found in heterochromatin, but can also occur at other silent regions.\n- Low ATAC-seq signal indicates reduced chromatin accessibility but does not by itself specify the underlying silencing pathway.\n\nWhich option best integrates these facts to provide the correct classification and the single minimal additional evidence needed?\n\nA. Constitutive heterochromatin; demonstrate local enrichment of Heterochromatin Protein 1 (HP1) by chromatin immunoprecipitation followed by sequencing (ChIP-seq) at the locus.\n\nB. Euchromatin; demonstrate high occupancy of RNA polymerase II with serine 2 phosphorylation (elongating polymerase) by ChIP-seq at the locus.\n\nC. Facultative heterochromatin; demonstrate occupancy of Polycomb Repressive Complex 2 (for example, EZH2) or increased $H3K27me3$ by ChIP-seq at the locus.\n\nD. Constitutive heterochromatin; demonstrate assignment to the B compartment by high-throughput chromosome conformation capture (Hi-C) A/B compartment analysis.\n\nE. Constitutive heterochromatin; demonstrate that deletion of SUV39H1/2 (histone H3 lysine 9 methyltransferases) derepresses the locus, using genome editing and transcriptome profiling.\n\nSelect the single best answer.", "solution": "The problem statement must first be validated for scientific soundness, clarity, and completeness.\n\n**Step 1: Extract Givens**\nThe problem describes a mammalian genomic locus with the following epigenomic characteristics, all measured in the same cell type and condition:\n1.  High trimethylation of histone H3 lysine 9 ($H3K9me3$).\n2.  Low trimethylation of histone H3 lysine 27 ($H3K27me3$).\n3.  Strong cytosine DNA methylation at CpG dinucleotides.\n4.  A very low signal in Assay for Transposase-Accessible Chromatin using sequencing (ATAC-seq).\n\nThe problem asks for two things:\n1.  Classification of the locus as euchromatin or heterochromatin.\n2.  Specification of a single, mechanistically informative and minimally sufficient additional measurement to resolve ambiguity about whether the locus is in the canonical constitutive heterochromatin pathway.\n\nThe problem provides the following foundational facts:\n- Euchromatin: accessible, activating marks, transcriptional potential.\n- Heterochromatin: compact, silenced, repressive marks, reader proteins.\n- $H3K9me3$: hallmark of constitutive heterochromatin, recognized by Heterochromatin Protein 1 (HP1).\n- $H3K27me3$: canonical mark of facultative heterochromatin, deposited by Polycomb Repressive Complex 2 (PRC2).\n- DNA methylation: correlates with repression, common in heterochromatin.\n- Low ATAC-seq signal: indicates reduced accessibility.\n\n**Step 2: Validate Using Extracted Givens**\n- **Scientific Grounding**: The problem uses standard terminology and concepts from the field of chromatin biology and epigenetics. The descriptions of histone marks ($H3K9me3$, $H3K27me3$), DNA methylation, chromatin accessibility (ATAC-seq), and their association with chromatin states (euchromatin, constitutive/facultative heterochromatin) are factually correct and consistent with established scientific principles.\n- **Well-Posedness**: The problem provides a set of consistent data points and asks for a logical deduction and the identification of a confirmatory experiment. This structure allows for a unique, reasoned solution. The question is clearly defined.\n- **Objectivity**: The problem is stated using objective, technical language. While terms like \"high\" and \"low\" are relative, they are standard descriptors in genomics and are unambiguous in this context for distinguishing between opposing chromatin states.\n\n**Step 3: Verdict and Action**\nThe problem is scientifically sound, well-posed, objective, and contains sufficient information for a rigorous analysis. It is therefore **valid**. I will proceed with a full solution.\n\n**Derivation of Solution**\n\nFirst, we must classify the chromatin state of the locus based on the given data.\n1.  **Low ATAC-seq signal**: This indicates that the chromatin is in a compacted, inaccessible state. This immediately rules out transcriptionally active euchromatin, which is characterized by high accessibility. The locus is therefore in a silent or repressed state, consistent with heterochromatin.\n2.  **High $H3K9me3$**: This histone modification is the canonical, defining mark of constitutive heterochromatin. Its presence is a very strong indicator of this chromatin state.\n3.  **Low $H3K27me3$**: This histone modification is the canonical mark of facultative heterochromatin, established by the activity of PRC2. The absence of this mark strongly argues against the locus being facultative heterochromatin.\n4.  **Strong DNA methylation**: This modification is strongly associated with stable gene silencing and is a common feature of constitutive heterochromatin, often acting synergistically with the $H3K9me3$ pathway.\n\nTaken together, the data (inaccessible chromatin, high $H3K9me3$, low $H3K27me3$, and strong DNA methylation) provides a clear and consistent signature for **constitutive heterochromatin**.\n\nSecond, we must identify a single, mechanistically informative, and minimally sufficient additional measurement to confirm that the locus is part of the *canonical constitutive heterochromatin pathway*. The canonical pathway is not merely the presence of the $H3K9me3$ mark, but the subsequent recruitment of effector proteins that recognize this mark to establish and maintain the compacted, silent state.\n\nAs stated in the foundational facts, $H3K9me3$ is specifically recognized by the chromodomain of Heterochromatin Protein 1 (HP1). The binding of HP1 to $H3K9me3$-marked nucleosomes is the critical mechanistic step that distinguishes the functional constitutive heterochromatin pathway from a region that may simply carry the $H3K9me3$ mark without the full downstream repressive machinery. Therefore, the most direct, informative, and minimal measurement to confirm the pathway's activity is to demonstrate the physical presence of the key effector protein, HP1, at this specific locus. The standard method for this is chromatin immunoprecipitation followed by sequencing (ChIP-seq) using an antibody against an HP1 isoform (e.g., HP1$\\alpha$, the product of the `CBX5` gene).\n\n**Evaluation of Options**\n\n*   **A. Constitutive heterochromatin; demonstrate local enrichment of Heterochromatin Protein 1 (HP1) by chromatin immunoprecipitation followed by sequencing (ChIP-seq) at the locus.**\n    *   The classification as \"Constitutive heterochromatin\" is correct.\n    *   The proposed additional measurement, ChIP-seq for HP1, directly tests for the presence of the key effector protein that reads the $H3K9me3$ mark. This is the most direct and mechanistically informative way to confirm that the canonical pathway is active at the locus. It is a single measurement performed on the native cells. This option is excellent.\n    *   Verdict: **Correct**.\n\n*   **B. Euchromatin; demonstrate high occupancy of RNA polymerase II with serine 2 phosphorylation (elongating polymerase) by ChIP-seq at the locus.**\n    *   The classification as \"Euchromatin\" is incorrect. All provided data point to a silent, heterochromatic state.\n    *   The proposed measurement would test for active transcription, which is the opposite of what is expected.\n    *   Verdict: **Incorrect**.\n\n*   **C. Facultative heterochromatin; demonstrate occupancy of Polycomb Repressive Complex 2 (for example, EZH2) or increased $H3K27me3$ by ChIP-seq at the locus.**\n    *   The classification as \"Facultative heterochromatin\" is incorrect. The data explicitly shows low levels of $H3K27me3$, the defining mark of this state.\n    *   The proposed measurement would test for the machinery of facultative heterochromatin, which is contradicted by the initial data.\n    *   Verdict: **Incorrect**.\n\n*   **D. Constitutive heterochromatin; demonstrate assignment to the B compartment by high-throughput chromosome conformation capture (Hi-C) A/B compartment analysis.**\n    *   The classification as \"Constitutive heterochromatin\" is correct.\n    *   The proposed measurement, assignment to the B compartment, is consistent with heterochromatin. However, the B compartment is a feature of large-scale genomic organization (typically hundreds of kilobases to megabases) and is correlational, not directly mechanistic at the level of a single locus. Many types of silent chromatin are found in the B compartment. Demonstrating HP1 binding (Option A) provides more specific, locus-level mechanistic information about the pathway involved, fulfilling the \"mechanistically informative\" criterion more precisely than a large-scale compartment assignment.\n    *   Verdict: **Incorrect**. This is a plausible but less precise and less mechanistically direct measurement compared to Option A.\n\n*   **E. Constitutive heterochromatin; demonstrate that deletion of SUV39H1/2 (histone H3 lysine 9 methyltransferases) derepresses the locus, using genome editing and transcriptome profiling.**\n    *   The classification as \"Constitutive heterochromatin\" is correct.\n    *   The proposed experiment is a powerful test of causality. However, the question asks for a \"single, ... additional *measurement*\". This option describes a complex perturbation experiment involving genome editing (a manipulation) followed by a measurement (transcriptome profiling). It is not a single measurement of the original, unperturbed biological state. A ChIP-seq experiment (Option A) is a single profiling measurement. Therefore, Option A better fits the constraint of being a \"single\" and \"minimally sufficient\" measurement to characterize the existing state, as opposed to a multi-step perturbation experiment designed to prove causality.\n    *   Verdict: **Incorrect**. While scientifically valuable, this experiment does not fit the specific constraints of the question as well as Option A.\n\nConclusion: Option A provides the correct classification and proposes the most direct, mechanistically informative, and minimally sufficient additional measurement to confirm the canonical constitutive heterochromatin pathway is active at the locus.", "answer": "$$\\boxed{A}$$", "id": "2944116"}, {"introduction": "The structural differences between euchromatin and heterochromatin have profound functional consequences. This practice moves from qualitative description to quantitative prediction by employing a simplified biophysical model of the chromatin fiber. You will derive how nucleosome repeat length—a key parameter that differs between open and closed chromatin—directly governs the statistical accessibility of DNA to binding proteins, providing a tangible link between structure and function [@problem_id:2944124].", "problem": "Consider a long chromatin fiber modeled as a one-dimensional (1D) periodic lattice in which each repeat consists of a nucleosome core particle of length $147$ base pair (bp) followed by an average linker of length $L$ bp. Thus, the nucleosome repeat length (NRL) is $NRL = 147 + L$. Assume the following foundational facts: a nucleosome core particle occludes deoxyribonucleic acid (DNA) from most transcription factor binding under steady-state conditions, while linker DNA is accessible; and a transcription factor (TF) binding site of length $m$ bp is accessible if and only if the entire $m$-bp motif lies within a linker segment (ignore transient nucleosomal unwrapping and boundary effects in the limit of a very long fiber).\n\nLet $m = 10$ bp. Define the accessible fraction $f(L,m)$ as the fraction of all possible motif start positions along the DNA that yield the full $m$-bp motif entirely within linker DNA, under the 1D lattice model above.\n\n1. Starting from the periodicity of the lattice and uniform sampling of motif start positions at single base-pair resolution, derive $f(L,m)$ as a function of $L$ and $m$, valid for $L \\ge m$.\n2. In euchromatin, take $L_{\\mathrm{eu}} = 60$ bp, and in heterochromatin, take $L_{\\mathrm{het}} = 20$ bp. Using your expression for $f(L,m)$, compute the ratio\n$$\nR \\equiv \\frac{f(L_{\\mathrm{eu}}, m)}{f(L_{\\mathrm{het}}, m)}.\n$$\nReport $R$ as a unitless decimal rounded to four significant figures.", "solution": "The problem statement is subjected to validation and is found to be scientifically grounded, well-posed, objective, and internally consistent. It presents a simplified but standard biophysical model of chromatin accessibility. All required parameters are defined, and the objectives are clear. Therefore, I will proceed with a full solution.\n\nThe problem is addressed in two parts. First, the derivation of the accessible fraction $f(L,m)$, and second, the computation of the ratio $R$ for specified chromatin states.\n\n1. Derivation of the accessible fraction $f(L,m)$.\nThe chromatin fiber is modeled as a one-dimensional periodic lattice. Each repeating unit, of total length known as the Nucleosome Repeat Length ($NRL$), is composed of a nucleosome core particle and a linker segment of deoxyribonucleic acid (DNA).\nThe length of the DNA wrapped in a nucleosome core particle is given as $147$ base pairs (bp).\nThe length of the linker DNA is given as $L$ bp.\nThe total length of one periodic unit is therefore $NRL = 147 + L$.\n\nWe assume uniform probability for the start position of a transcription factor (TF) binding motif along the DNA. Due to the periodicity of the lattice, we can analyze the accessibility within a single repeat unit of length $NRL$ to determine the overall accessible fraction. The total number of possible start positions for a motif within one repeat unit, at single base-pair resolution, is equal to the length of the unit, $NRL = 147 + L$.\n\nA TF binding motif of length $m$ bp is defined as accessible if and only if the entire motif is located within a linker DNA segment. The nucleosomal DNA, of length $147$ bp, is considered inaccessible. The linker DNA, of length $L$ bp, is considered accessible.\n\nLet us consider one repeat unit. We can place the linker DNA segment first, occupying positions $1, 2, \\dots, L$. The nucleosomal DNA follows, occupying positions $L+1, \\dots, L+147$. The specific arrangement within the unit is irrelevant due to periodicity when considering a long fiber.\nFor a motif of length $m$ to lie entirely within the linker DNA, its start position, $s$, and end position, $s+m-1$, must both be within the bounds of the linker segment.\nSo, we must satisfy the conditions:\n$$s \\ge 1$$\n$$s+m-1 \\le L$$\nThe second inequality can be rearranged to find the upper bound for the start position $s$:\n$$s \\le L - m + 1$$\nThus, the permissible start positions for an accessible motif are all integers $s$ such that $1 \\le s \\le L-m+1$.\n\nThe number of such integer positions, $N_{\\text{accessible}}$, is given by the count of integers in this range:\n$$N_{\\text{accessible}} = (L-m+1) - 1 + 1 = L-m+1$$\nThis formula is valid provided that $L-m+1 \\ge 1$, which simplifies to $L \\ge m$. The problem statement explicitly provides this condition for the derivation. If $L < m$, it would be impossible to fit the motif in the linker, and the number of accessible sites would be $0$. Our expression $L-m+1$ handles the boundary case $L=m-1$ correctly (giving $0$), but for $L < m-1$ it would give a non-physical negative result. However, we operate under the constraint $L \\ge m$.\n\nThe accessible fraction, $f(L,m)$, is defined as the ratio of the number of accessible start positions to the total number of possible start positions within one repeat unit.\n$$f(L,m) = \\frac{N_{\\text{accessible}}}{N_{\\text{total}}} = \\frac{L-m+1}{147+L}$$\nThis is the general expression for the accessible fraction for a motif of length $m$ on a lattice with linker length $L$, valid for $L \\ge m$.\n\n2. Computation of the ratio $R$.\nWe are given the following values:\n- Motif length: $m = 10$ bp.\n- Euchromatin linker length: $L_{\\mathrm{eu}} = 60$ bp.\n- Heterochromatin linker length: $L_{\\mathrm{het}} = 20$ bp.\nBoth $L_{\\mathrm{eu}}$ and $L_{\\mathrm{het}}$ satisfy the condition $L \\ge m$.\n\nFirst, we compute the accessible fraction for euchromatin, $f(L_{\\mathrm{eu}}, m)$:\n$$f(L_{\\mathrm{eu}}, m) = f(60, 10) = \\frac{60-10+1}{147+60} = \\frac{51}{207}$$\nThis fraction can be simplified. The numerator is $51 = 3 \\times 17$. The denominator is $207 = 9 \\times 23$.\n$$f(L_{\\mathrm{eu}}, m) = \\frac{3 \\times 17}{9 \\times 23} = \\frac{17}{3 \\times 23} = \\frac{17}{69}$$\n\nNext, we compute the accessible fraction for heterochromatin, $f(L_{\\mathrm{het}}, m)$:\n$$f(L_{\\mathrm{het}}, m) = f(20, 10) = \\frac{20-10+1}{147+20} = \\frac{11}{167}$$\nThe number $11$ is prime, and $167$ is also a prime number. This fraction is irreducible.\n\nFinally, we compute the ratio $R \\equiv \\frac{f(L_{\\mathrm{eu}}, m)}{f(L_{\\mathrm{het}}, m)}$:\n$$R = \\frac{f(60, 10)}{f(20, 10)} = \\frac{51/207}{11/167} = \\frac{51}{207} \\cdot \\frac{167}{11}$$\nUsing the simplified fraction for $f(L_{\\mathrm{eu}}, m)$:\n$$R = \\frac{17}{69} \\cdot \\frac{167}{11} = \\frac{17 \\times 167}{69 \\times 11} = \\frac{2839}{759}$$\nTo provide the answer as a decimal rounded to four significant figures, we perform the division:\n$$R = \\frac{2839}{759} \\approx 3.7404479578...$$\nRounding to four significant figures gives:\n$$R \\approx 3.740$$\nThis result quantifies the higher accessibility of TF binding sites in euchromatin compared to heterochromatin, as predicted by this simple model. The longer linkers in euchromatin provide disproportionately more accessible DNA for TF binding.", "answer": "$$\\boxed{3.740}$$", "id": "2944124"}, {"introduction": "The ultimate goal of mechanistic biology is to move beyond correlation to establish causation. While we know certain histone marks are associated with heterochromatin, is their presence alone *sufficient* to create it? This practice places you at the frontier of experimental epigenetics, asking you to design a definitive experiment using cutting-edge tools like dCas9-based epigenome editing to test this very hypothesis, paying careful attention to the critical controls and readouts needed for an unambiguous conclusion [@problem_id:2944203].", "problem": "You are asked to test whether deposition of the histone modification $H3K9me3$ is, by itself in an otherwise unmanipulated cell, sufficient to induce a local heterochromatin-like state. Starting only from the following foundational bases: (i) the Central Dogma of Molecular Biology (DNA is transcribed to RNA, which is translated to protein), (ii) the reader–writer–eraser paradigm for chromatin modifications (writers deposit marks, readers bind marks and effect downstream structure/function, erasers remove marks), and (iii) the widely observed relationship that heterochromatin is characterized by increased nucleosome density and compaction, reduced transcriptional output, and occupancy of specific readers such as Heterochromatin Protein 1 (HP1) at $H3K9me3$, choose the best experimental design and outcome pattern to test sufficiency of $H3K9me3$ at an active locus.\n\nEach option below proposes: (a) a recruitment strategy, (b) core controls, and (c) expected changes in chromatin accessibility, transcription, and reader occupancy at the targeted locus. Select the single option whose design and predicted outcomes most directly and correctly test whether $H3K9me3$ deposition alone is sufficient to induce a heterochromatin-like state.\n\nA. Recruit a catalytically active suppressor of variegation 3-9 homolog 1 (SUV39H1) SET domain to a single-copy, constitutively expressed green fluorescent protein reporter integrated at a safe harbor locus using catalytically dead Clustered Regularly Interspaced Short Palindromic Repeats-associated protein 9 (dCas9) targeted by guide RNAs to the promoter and first intron. Induce recruitment acutely with a small-molecule dimerizer and profile local changes by Assay for Transposase-Accessible Chromatin using sequencing (ATAC-seq), nascent transcription by Precision Run-On sequencing (PRO-seq), Chromatin ImmunoPrecipitation followed by sequencing (ChIP-seq) for $H3K9me3$ and HP1, and RNA polymerase II occupancy. Controls: a catalytically dead SUV39H1 SET mutant tethered identically, a no-guide RNA control, and an isogenic HP1 depletion line. Expected outcomes: with active SUV39H1, a focal increase in $H3K9me3$ and HP1 occupancy at the targeted locus, accompanied by decreased ATAC-seq accessibility and decreased nascent transcription and RNA polymerase II occupancy at that locus, with no change at non-target loci. In the catalytically dead and no-guide controls, no changes. In the HP1-depleted line, increased $H3K9me3$ occurs but accessibility and transcription are not substantially reduced, indicating that while installed $H3K9me3$ can be sufficient to induce a heterochromatin-like state in the presence of its endogenous reader, the compaction aspect requires HP1.\n\nB. Recruit enhancer of zeste homolog 2 (EZH2) catalytic domain to the same reporter using dCas9. Controls: catalytically dead EZH2 and no-guide RNA. Expected outcomes: increased $H3K9me3$, increased HP1 occupancy, reduced ATAC-seq accessibility, and reduced transcription at the targeted locus, with no changes in controls.\n\nC. Recruit active SUV39H1 SET domain to the reporter as in A, with controls identical to A. Expected outcomes: increased $H3K9me3$ at the target accompanied by increased chromatin accessibility due to nucleosome eviction, increased nascent transcription, and decreased HP1 occupancy, arguing that the mark alone destabilizes nucleosomes at active genes.\n\nD. Recruit HP1 alone to the reporter using a lac repressor–operator system without any writer enzyme. Controls: recruitment of a non-chromatin-binding mutant of HP1 and no lac operator. Expected outcomes: increased $H3K9me3$ at the locus via feed-forward recruitment of writers, decreased ATAC-seq accessibility, and reduced transcription, establishing that reader recruitment is sufficient to install the mark and compact chromatin.\n\nE. Recruit lysine demethylase 4 (KDM4) to the reporter using dCas9 to remove $H3K9me3$. Controls: catalytically dead KDM4 and no-guide RNA. Expected outcomes: loss of $H3K9me3$, loss of HP1 occupancy, increased accessibility, and increased transcription, thereby demonstrating that $H3K9me3$ is sufficient to repress when present.\n\nWhich option is the best design and prediction set to directly test the sufficiency of $H3K9me3$ deposition for inducing a heterochromatin-like state at a euchromatic locus while specifying appropriate controls and readouts?", "solution": "The problem asks for the design of an experiment to test the sufficiency of histone H3 lysine 9 trimethylation ($H3K9me3$) deposition in inducing a heterochromatin-like state at a euchromatic locus. To test for sufficiency, one must introduce the component in question—in this case, the $H3K9me3$ mark—into a system that initially lacks it, and then observe whether the expected downstream effects manifest. The system is a euchromatic, or transcriptionally active, locus. The effect to be observed is the formation of a heterochromatin-like state, which the problem defines as possessing increased nucleosome compaction (reduced accessibility), reduced transcription, and recruitment of the canonical $H3K9me3$ reader protein, Heterochromatin Protein 1 (HP1).\n\nA rigorous experimental design to test for sufficiency must therefore have the following components:\n$1$. A method to deposit $H3K9me3$ specifically at a chosen active gene. This requires targeting the catalytic domain of an $H3K9me3$-specific histone methyltransferase (a \"writer\") to the locus. The canonical writer for constitutive heterochromatin's $H3K9me3$ is suppressor of variegation 3-9 homolog 1 (SUV39H1). A programmable DNA-binding platform, such as the catalytically dead Clustered Regularly Interspaced Short Palindromic Repeats-associated protein 9 (dCas9), is the state-of-the-art tool for such targeting.\n$2$. A-set of quantitative readouts to measure both the cause and the effect. To confirm the writer's action, Chromatin ImmunoPrecipitation followed by sequencing (ChIP-seq) for $H3K9me3$ is necessary. To measure the downstream effects, one must assay for HP1 recruitment (e.g., HP1 ChIP-seq), changes in chromatin accessibility (e.g., Assay for Transposase-Accessible Chromatin using sequencing, or ATAC-seq), and changes in transcription (e.g., nascent transcription profiling with Precision Run-On sequencing, or PRO-seq, and RNA polymerase II occupancy by ChIP-seq).\n$3$. A-set of stringent controls to isolate the effect of the writer's catalytic activity from other potential artifacts. A critical control is the recruitment of a catalytically inactive version of the writer enzyme to the same locus. This distinguishes effects of the enzymatic activity (i.e., histone methylation) from effects of simply tethering a large protein complex to the DNA. Another essential control is a non-targeting condition (e.g., no guide RNA) to ensure the observed effects are locus-specific.\n\nWe will now evaluate each option against these principles.\n\nA. This option proposes recruiting a catalytically active SUV39H1 SET domain using dCas9 to an active reporter. This correctly identifies the writer (SUV39H1) and targeting system (dCas9). The chosen readouts (ATAC-seq for accessibility, PRO-seq for transcription, ChIP-seq for $H3K9me3$, HP1, and RNA polymerase II) are comprehensive and appropriate for measuring the predicted effects. The proposed controls are exceptionally rigorous: ($1$) a catalytically dead SUV39H1 mutant to control for effects of protein tethering, ($2$) a no-guide RNA control for targeting specificity, and ($3$) an isogenic HP1 depletion line to dissect the downstream mechanism. The expected outcomes are biologically sound: focal deposition of $H3K9me3$ leads to HP1 recruitment, chromatin compaction (decreased ATAC-seq), and transcriptional repression (decreased PRO-seq and RNA Pol II occupancy). The predicted result in the HP1-depleted line—that $H3K9me3$ is deposited but compaction and repression are attenuated—correctly isolates the role of the reader HP1 as a crucial mediator of the mark's downstream structural effects. This constitutes a direct, well-controlled, and mechanistically insightful test of sufficiency. The conclusion that $H3K9me3$ is sufficient to induce a heterochromatin-like state in the presence of its reader is a precise interpretation of such data.\n**Verdict: Correct.**\n\nB. This option proposes recruiting the enhancer of zeste homolog 2 (EZH2) catalytic domain. This is a fundamental scientific error. EZH2 is the histone methyltransferase responsible for depositing the repressive mark $H3K27me3$, not $H3K9me3$. The $H3K27me3$ mark is associated with facultative heterochromatin and Polycomb-mediated repression, which involves a different set of readers and mechanisms than $H3K9me3$/HP1-mediated constitutive heterochromatin. Therefore, this experiment does not test the hypothesis about $H3K9me3$. Consequently, the predicted outcome of increased $H3K9me3$ and HP1 occupancy is incorrect.\n**Verdict: Incorrect.**\n\nC. This option correctly proposes to recruit the SUV39H1 SET domain. However, it predicts biologically implausible outcomes: increased chromatin accessibility and increased nascent transcription. These effects are the opposite of what defines heterochromatin formation. The foundational premise of the problem states that heterochromatin is characterized by compaction and reduced transcription. An experimental design that predicts a result contradicting the fundamental phenomenon it seeks to create is logically and scientifically flawed.\n**Verdict: Incorrect.**\n\nD. This option proposes to recruit the reader protein HP1 directly, not the writer enzyme. The question is to test the sufficiency of the *mark deposition* ($H3K9me3$ installation). This experiment, instead, tests the sufficiency of the *reader* (HP1) to induce a heterochromatic state. While tethering HP1 can indeed lead to the recruitment of writers and formation of heterochromatin through a positive feedback loop, it is an indirect test of the primary hypothesis. The initial causal agent in the experiment is the reader, not the mark. A direct test of the mark's sufficiency requires the mark to be the primary experimental perturbation.\n**Verdict: Incorrect.**\n\nE. This option proposes to recruit a lysine demethylase, KDM4, to *remove* $H3K9me3$. An experiment where a component is removed to see if a particular state is lost is a test for *necessity*, not *sufficiency*. To test sufficiency, one must add the component to a system that lacks it. This experiment is correctly designed to test if $H3K9me3$ is necessary to maintain a pre-existing heterochromatic state, but it does not address whether its deposition is sufficient to establish such a state *de novo* at a euchromatic region. The framing of the question is explicitly about sufficiency.\n**Verdict: Incorrect.**\n\nIn summary, option A provides the only experimental design that is scientifically sound, directly addresses the question of sufficiency, includes a complete and rigorous set of controls, and proposes a biologically correct and mechanistically informative set of outcomes.", "answer": "$$\\boxed{A}$$", "id": "2944203"}]}